Novartis Investigative Site

Hong Kong

0 studies enrolling now · 2 studies all time

What they study most

Acute Lymphoblastic Leukemia, Diabetes Mellitus, Type 2

Studies at this site

• A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia Patients — Completed
• Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients — Stopped early